Clinical Trials Directory

Trials / Unknown

UnknownNCT01156064

Confocal Laser Endomicroscopy in Digestive Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

Confocal laser endomicroscopy (CLE) is a newly endoscopic device that enables microscopic view of the digestive tract. The purpose of this study is to determine if confocal laser endomicroscopy can improve detection of digestive disease include inflammation, dysplasia, and early cancer, and if confocal laser endomicroscopy has competitive advantage, compared with other device such as Narrow Band Imaging and Autofluoresecence Imaging.

Detailed description

Advances in endoscopy have led to imagining of the details of digestive mucosa. Novel techniques such as Narrow Band Imaging (NBI) assisted magnification endoscopy, Auto Fluorescence Imaging (AFI) or confocal laser endomicroscopy could, however, improve the endoscopic detection.In this research we describe the combined use of these three techniques in patients with digestive disease.

Conditions

Interventions

TypeNameDescription
DEVICEConfocal Laser Endomicroscopy (Pentax/Optiscan)Confocal laser endomicroscopy is performed using the Pentax/Optiscan confocal endomicroscopy and 5 ml of 10% intravenous fluorescein sodium. Photos of magnified images of the digestive mucosa are taken during the procedure.
DEVICENarrow Band Imaging/Auto Fluorescence Imaging (Olympus)NBI/AFI endoscope offers an alternative light source involve NBI and AFI to view digestive mucosa in real time.

Timeline

Start date
2008-08-01
Primary completion
2009-12-01
Completion
2011-12-01
First posted
2010-07-02
Last updated
2010-11-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01156064. Inclusion in this directory is not an endorsement.